QuidelOrtho (QDEL) Non-Current Deferred Tax Liability (2022 - 2026)
QuidelOrtho's (QDEL) quarterly Non-Current Deferred Tax Liability came in at $87.3 million in Q1 2026, up 11.64% year-on-year from $78.2 million in Q1 2025, and down 3.0% quarter-over-quarter from $90.0 million in Q4 2025.
QuidelOrtho (QDEL) Non-Current Deferred Tax Liability (2022 - 2026) Analysis & Trends
QuidelOrtho has disclosed Non-Current Deferred Tax Liability across 5 years of filings, most recently posting $87.3 million for Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $87.3 million, up 11.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $87.3 million (up 11.64% YoY), and the FY2025 annual result was $90.0 million, up 17.65% from the prior year.
- Non-Current Deferred Tax Liability came in at $87.3 million for Q1 2026 at QuidelOrtho, down from $90.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $707.4 million in Q4 2023 to a low of $76.5 million in Q4 2024.
- The 5-year median for Non-Current Deferred Tax Liability is $126.8 million (2024), against an average of $178.8 million.
- Across the five-year window, Non-Current Deferred Tax Liability soared 231.8% in 2023 and slumped 89.19% in 2024, its largest moves.
- QuidelOrtho's Non-Current Deferred Tax Liability stood at $256.4 million in 2022, then soared by 175.9% to $707.4 million in 2023, then plunged by 89.19% to $76.5 million in 2024, then climbed by 17.65% to $90.0 million in 2025, then retreated by 3.0% to $87.3 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $87.3 million (Q1 2026), $90.0 million (Q4 2025), and $80.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | QuidelOrtho | 934.34 Mn | 793.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 87.30 Mn |
| Mar 29, 2026 | 87.30 Mn |
| Dec 28, 2025 | 90.00 Mn |
| Dec 28, 2025 | 90.00 Mn |
| Sep 28, 2025 | 80.10 Mn |
| Sep 28, 2025 | 80.10 Mn |
| Jun 29, 2025 | 82.80 Mn |
| Jun 29, 2025 | 82.80 Mn |
| Mar 30, 2025 | 78.20 Mn |
| Mar 30, 2025 | 78.20 Mn |
| Dec 29, 2024 | 76.50 Mn |
| Dec 29, 2024 | 76.50 Mn |
| Sep 29, 2024 | 117.20 Mn |
| Sep 29, 2024 | 117.20 Mn |
| Jun 30, 2024 | 127.90 Mn |
| Jun 30, 2024 | 127.90 Mn |
| Mar 31, 2024 | 125.60 Mn |
| Mar 31, 2024 | 125.60 Mn |
| Dec 31, 2023 | 707.40 Mn |
| Dec 31, 2023 | 707.40 Mn |